Medicine & Life Sciences
Telmisartan
100%
Angiotensin Type 1 Receptor
86%
Parkinsonian Disorders
77%
Parkinson Disease
59%
Vesicular Monoamine Transport Proteins
53%
Angiotensin II Type 1 Receptor Blockers
47%
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
44%
Dopamine Plasma Membrane Transport Proteins
43%
Glial Fibrillary Acidic Protein
39%
Tyrosine 3-Monooxygenase
38%
Nerve Growth Factors
37%
Nitric Oxide Synthase Type II
37%
Neuroprotective Agents
36%
Inbred C57BL Mouse
33%
Glutathione
31%
Neuroglia
31%
Dopamine
29%
Nitric Oxide
28%
Chronic Disease
26%
Up-Regulation
25%
Down-Regulation
24%
Therapeutics
5%
Chemical Compounds
Telmisartan
100%
Angiotensin Type 1 Receptor
28%
Neuroglia
20%
Vesicular Monoamine Transport Proteins
17%
Angiotensin II Type 1 Receptor Blockers
15%
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
14%
Dopamine Plasma Membrane Transport Proteins
14%
Glial Fibrillary Acidic Protein
13%
Tyrosine 3-Monooxygenase
12%
Nerve Growth Factors
12%
Nitric Oxide Synthase Type II
12%
Neuroprotective Agents
12%
Glutathione
10%
Dopamine
9%
Nitric Oxide
9%